<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3692545&amp;fmt=gif">

How OxyContin Paved the Path to Fentanyl: a Doctor’s Perspective

Michael Brown
Michael Brown
Michael W. Brown is the global director of counter-narcotics technology at Rigaku Analytical Devices. He has a distinguished career spanning more than 32 years as a Special Agent for the Drug Enforcement Administration (DEA). Most recently he was the DEA Headquarters staff coordinator for the Office of Foreign Operations for the Middle East-Europe-Afghanistan-India. Prior to that he served as the country attaché in India and Myanmar providing foreign advisory support for counter narcotic enforcement. He also spent 10 years in Pakistan as a special advisor to the US Embassy on various law enforcement issues. Michael is a graduate of the United States Ranger Training Battalion and has a master’s degree in Interdisciplinary Technology and Management from the University of Eastern Michigan.
    

 

When OxyContin was approved in the 90's, how many could predict the skyrocketing opioid-related deaths in the road ahead?  As we scramble to treat a now fentanyl-dominated market, what lessons can we learn from the past to prevent the next stage of the opioid epidemic evolution?

In this episode we speak with Dr. Arun Gupta MD PC, Addiction Specialist, Family Physician and author of The Preventable Epidemic.  Dr. Gupta discusses the events that led the opioid epidemic to spiral out of control and what we can do to stop it before it gets even worse.

Key topics:

  • How OxyContin paved the way to fentanyl
  • Better methods to taper off of opioids
  • The role of addiction training in medical practice


 

Listen and subscribe on your favorite podcast player:

Spotify

Apple Podcasts

Google Podcasts


To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player here: https://plinkhq.com/i/1625927161?to=page